Loss of Metabolic Fitness Drives Tumor Resistance after CAR-NK Cell Therapy and Can Be Overcome by Cytokine Engineering

Scientists performed single-cell RNA sequencing and mass cytometry to study the heterogeneity of CAR-natural killer (NK) cells and their in vivo evolution after adoptive transfer, from the phase of tumor control to relapse.